Migraine and obesity: Cause or effect?

Headache

Volumn 50, Issue 2, 2010, Pages 326-328

  Ray, Stephen T J ^a   Kumar, Ram ^a  

^a ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NEUROTRANSMITTER; OREXIN 1 RECEPTOR; OREXIN 1 RECEPTOR ANTAGONIST; OREXIN A; RECEPTOR BLOCKING AGENT; SEROTONIN; SEROTONIN AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; APPETITE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CASE CONTROL STUDY; CEREBROSPINAL FLUID LEVEL; CHILD; CHRONIC PAIN; CONTROLLED STUDY; DISABILITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FAT INTAKE; FAT MASS AND OBESITY ASSOCIATED GENE; FEEDING BEHAVIOR; GENE; GENE EXPRESSION; GENOTYPE; HEADACHE; HUMAN; HYPOTHALAMUS; LETTER; MAJOR CLINICAL STUDY; MIGRAINE; NEUROTRANSMISSION; NONHUMAN; OBESITY; PREVALENCE; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; RISK FACTOR; SATIETY; SEROTONINERGIC SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; TENSION HEADACHE;

ADIPOSE TISSUE; AGE FACTORS; AGING; ANIMALS; APPETITE REGULATION; CAUSALITY; CHILD; COMORBIDITY; FEEDING BEHAVIOR; HUMANS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIGRAINE DISORDERS; NEUROPEPTIDES; OBESITY; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 75849152227     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2009.01539.x     Document Type: Letter

References (28)

1. Hershey AD, Powers SW, Nelson TD, et al. American Headache Society Pediatric Adolescent Section. Obesity in the pediatric headache population: A multicenter study. Headache. 2009 49: 170 177.
2. Ness AR. The Avon Longitudinal Study of Parents and Children (ALSPAC)-A resource for the study of the environmental determinants of childhood obesity. Eur J Endocrinol. 2004 151: U141 U149.
3. Cole TJ, Faith MS, Pietrobelli A, Heo M. What is the best measure of adiposity change in growing children: BMI, BMI %, BMI z-score or BMI centile? Eur J Clin Nutr. 2005 59: 419 425.
4. Bigal ME, Lipton RB, Holland PR, Goadsby PJ. Obesity, migraine, and chronic migraine: Possible mechanisms of interaction. Neurology. 2007 68: 1851 1861.
5. Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not for chronic tension-type headache. Neurology. 2006 67: 252 257.
6. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: A population study. Neurology. 2006 66: 545 550.
7. Pinhas-Hamiel O, Frumin K, Gabis L, et al. Headaches in overweight children and adolescents referred to a tertiary-care centre in Israel. Obesity. 2008 16: 659 663.
8. Bigal ME, Lipton RB. What predicts the change from episodic to chronic migraine? Curr Opin Neurol. 2009 22: 269 276.
9. Gram DX, Hansen AJ, Wilken M, et al. Plasma calcitonin gene-related peptide is increased prior to obesity, and sensory nerve desensitization by capsaicin improves oral glucose tolerance in obese Zucker rats. Eur J Endocrinol. 2005 153: 963 969.
10. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J. CGRP may play a causative role in migraine. Cephalalgia. 2002 22: 54 61.
11. Goadsby P, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain. 1994 117: 427 434.
12. Olesen J, Diener HC, Husstedt iw, et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med. 2004 350: 1104 1110.
13. Mannix LK, Fan X, Assaid C, et al. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology. 2008 70: 1304 1312.
14. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990 28: 183 187.
15. Blundell JE. Is there a role for serotonin (5-hydroxytryptamine) in feeding? Int J Obes. 1977 1: 15 42.
16. Blundell JE, Halford JCG. Serotonin and appetite regulation: Implications for the pharmacological treatment of obesity. CNS Drugs. 1998 9: 473 495.
17. Halford JC, Blundell JE. Separate systems for serotonin and leptin in appetite control. Ann Med. 2000 32: 222 232.
18. Sarchielli P, Rainero I, Coppola F, et al. Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: Findings from cerebrospinal fluid. Cephalalgia. 2008 28: 714 722.
19. Bingham S, Davey PT, Babbs AJ, et al. Orexin-A, an hypothalamic peptide with analgesic properties. Pain. 2001 92: 81 90.
20. Rodgers RJ, Ishii Y, Halford JC, Blundell JE. Orexins and appetite regulation. Neuropeptides. 2002 36: 303 325.
21. Rodgers RJ, Halford JC, Nunes de Souza RL, et al. Dose-response effects of orexin-A on food intake and the behavioural satiety sequence in rats. Regul Pept. 2000 96: 71 84.
22. Rodgers RJ, Halford JC, Nunes de Souza RL, et al. SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur J Neurosci. 2001 13: 1444 1452.
23. Wardle J, Llewellyn C, Sanderson S, Plomin R. The FTO gene and measured food intake in children. Int J Obes. 2009 33: 42 45.
24. Cecil JE, Tavendale R, Watt P, Hetherington MM, Palmer CN. An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med. 2008 359: 2558 2566.
25. Wardle J, Carnell S, Haworth CM, Farooqi IS, O'Rahilly S, Plomin R. Obesity associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab. 2008 93: 3640 3643.
26. Willer CJ, Speliotes EK, Loos RJ, et al. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet. 2009 41: 25 34.
27. Carnell S, Wardle J. Appetite and adiposity in children: Evidence for a behavioral susceptibility theory of obesity. Am J Clin Nutr. 2008 88: 22 29.
28. Carnell S, Wardle J. Appetitive traits and child obesity: Measurement, origins and implications for intervention. Proc Nutr Soc. 2008 67: 343 355.